Search
Enlarge Text | Printable Version | Sitemap | Contact us
Research
Upcoming Events
Researcher Name: Emma King Affiliated Staff: Supervisors: Dr James Mittra and Professor David Wield Project Start Date: 01.09.2009 Project End Date: Contact Details: Emma King - e.k.king@sms.ed.ac.uk Funder: ESRC CASE studentship in partnership with Scottish Stem Cell Network and Scottish National Blood Transfusion Service Background: This project is undertaken in partnership with the Scottish Stem Cell Network (SSCN) and the Scottish National Blood Transfusion Service (SNBTS) and aims to investigate the range of viable public and private sector innovation trajectories, business models and hybrid approaches to the development of clinical stem cell therapies. Aims and Objectives: Aims: Develop a research based analysis of potential innovation processes and models for translating basic stem cell science into viable therapies, including the public sector, the commercial sector and public-private partnerships. Develop a research based analysis of regulatory developments related to stem cell therapies, such as the European Advanced Therapies Regulation, and explore connections with emerging innovative trajectories for stem cells Apply improved understanding of these issues to make recommendations on how to improve translational models to facilitate therapeutic innovations that are safe, affordable and publicly acceptable. The key research objectives are to: Develop a detailed understanding of the governance of early stage stem cell research, recognising different ethical and moral positions, and relate new governance and regulatory agendas to the development of innovative therapies. Interview key actors in the public and private sphere and uncover the factors that may encourage or constrain therapeutic advance. Use original data to develop an integrated framework for analysing the interactions amongst scientific and clinical developments, which will be of interest to the academic community, policy-makers and the interests and concerns of the non-academic partner organisations (SNBTS and SSCN). Disseminate the outcomes to both academic and non-academic users through peer reviewed publications, conference/workshop presentations and short policy reports. Research Methods: The research will be carried out using semi-structured interviews with actors in the field, alongside participant observation of laboratory work at SNBTS. Key Findings: Wider implications for policy: Key outputs will include analysis of the impact of the current European ethical, legal and regulatory environment on long-term investment in the development of stem cell therapies in the UK; recommendations on appropriate business models within the current environment, as well as more general policy advice to key stakeholders on balancing the need for private investment against broader public concerns. Project Update: Publications: External Links: Further information:
ESRC CASE studentship in partnership with Scottish Stem Cell Network and Scottish National Blood Transfusion Service
This project is undertaken in partnership with the Scottish Stem Cell Network (SSCN) and the Scottish National Blood Transfusion Service (SNBTS) and aims to investigate the range of viable public and private sector innovation trajectories, business models and hybrid approaches to the development of clinical stem cell therapies.
Aims:
The key research objectives are to:
The research will be carried out using semi-structured interviews with actors in the field, alongside participant observation of laboratory work at SNBTS.
Key outputs will include analysis of the impact of the current European ethical, legal and regulatory environment on long-term investment in the development of stem cell therapies in the UK; recommendations on appropriate business models within the current environment, as well as more general policy advice to key stakeholders on balancing the need for private investment against broader public concerns.
